Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309682774> ?p ?o ?g. }
- W4309682774 endingPage "1963" @default.
- W4309682774 startingPage "1963" @default.
- W4309682774 abstract "Despite the progress in the comprehension of LC progression, risk, immunologic control, and treatment choices, it is still the primary cause of cancer-related death. LC cells possess a very low and heterogeneous antigenicity, which allows them to passively evade the anticancer defense of the immune system by educating cytotoxic lymphocytes (CTLs), tumor-infiltrating lymphocytes (TILs), regulatory T cells (Treg), immune checkpoint inhibitors (ICIs), and myeloid-derived suppressor cells (MDSCs). Though ICIs are an important candidate in first-line therapy, consolidation therapy, adjuvant therapy, and other combination therapies involving traditional therapies, the need for new predictive immunotherapy biomarkers remains. Furthermore, ICI-induced resistance after an initial response makes it vital to seek and exploit new targets to benefit greatly from immunotherapy. As ICIs, tumor mutation burden (TMB), and microsatellite instability (MSI) are not ideal LC predictive markers, a multi-parameter analysis of the immune system considering tumor, stroma, and beyond can be the future-oriented predictive marker. The optimal patient selection with a proper adjuvant agent in immunotherapy approaches needs to be still revised. Here, we summarize advances in LC immunotherapy approaches with their clinical and preclinical trials considering cancer models and vaccines and the potential of employing immunology to predict immunotherapy effectiveness in cancer patients and address the viewpoints on future directions. We conclude that the field of lung cancer therapeutics can benefit from the use of combination strategies but with comprehension of their limitations and improvements." @default.
- W4309682774 created "2022-11-29" @default.
- W4309682774 creator A5011289165 @default.
- W4309682774 creator A5014754030 @default.
- W4309682774 creator A5018841887 @default.
- W4309682774 creator A5019159253 @default.
- W4309682774 creator A5020796741 @default.
- W4309682774 creator A5028591119 @default.
- W4309682774 creator A5029173848 @default.
- W4309682774 creator A5032375199 @default.
- W4309682774 creator A5032951369 @default.
- W4309682774 creator A5033750623 @default.
- W4309682774 creator A5035628217 @default.
- W4309682774 creator A5038170170 @default.
- W4309682774 date "2022-11-19" @default.
- W4309682774 modified "2023-10-01" @default.
- W4309682774 title "Advances in the Lung Cancer Immunotherapy Approaches" @default.
- W4309682774 cites W1254044211 @default.
- W4309682774 cites W1480729244 @default.
- W4309682774 cites W1500124513 @default.
- W4309682774 cites W1553911486 @default.
- W4309682774 cites W1571559303 @default.
- W4309682774 cites W1577201120 @default.
- W4309682774 cites W1608585167 @default.
- W4309682774 cites W1642362876 @default.
- W4309682774 cites W1702502468 @default.
- W4309682774 cites W173584949 @default.
- W4309682774 cites W1829526068 @default.
- W4309682774 cites W1902684066 @default.
- W4309682774 cites W1910881826 @default.
- W4309682774 cites W1920235745 @default.
- W4309682774 cites W1955893089 @default.
- W4309682774 cites W1962635928 @default.
- W4309682774 cites W1964056896 @default.
- W4309682774 cites W1968762811 @default.
- W4309682774 cites W1976199086 @default.
- W4309682774 cites W1982488143 @default.
- W4309682774 cites W1983061784 @default.
- W4309682774 cites W1983501060 @default.
- W4309682774 cites W1989796113 @default.
- W4309682774 cites W1990626198 @default.
- W4309682774 cites W1991050083 @default.
- W4309682774 cites W1993615391 @default.
- W4309682774 cites W1994599132 @default.
- W4309682774 cites W1994993231 @default.
- W4309682774 cites W1996962547 @default.
- W4309682774 cites W2002339959 @default.
- W4309682774 cites W2004630197 @default.
- W4309682774 cites W2010671639 @default.
- W4309682774 cites W2017095275 @default.
- W4309682774 cites W2018092044 @default.
- W4309682774 cites W2023479489 @default.
- W4309682774 cites W2027925515 @default.
- W4309682774 cites W2029685983 @default.
- W4309682774 cites W2029744149 @default.
- W4309682774 cites W2032166347 @default.
- W4309682774 cites W2035313744 @default.
- W4309682774 cites W2035803798 @default.
- W4309682774 cites W2036123202 @default.
- W4309682774 cites W2041515126 @default.
- W4309682774 cites W2042174419 @default.
- W4309682774 cites W2044519844 @default.
- W4309682774 cites W2046972425 @default.
- W4309682774 cites W2047209914 @default.
- W4309682774 cites W2049193229 @default.
- W4309682774 cites W2049553585 @default.
- W4309682774 cites W2050458717 @default.
- W4309682774 cites W2050749285 @default.
- W4309682774 cites W2050941607 @default.
- W4309682774 cites W2052625497 @default.
- W4309682774 cites W2052727153 @default.
- W4309682774 cites W2054831292 @default.
- W4309682774 cites W2054931962 @default.
- W4309682774 cites W2057544900 @default.
- W4309682774 cites W2057574963 @default.
- W4309682774 cites W2060411131 @default.
- W4309682774 cites W2060974366 @default.
- W4309682774 cites W2061462324 @default.
- W4309682774 cites W2069643269 @default.
- W4309682774 cites W2071478196 @default.
- W4309682774 cites W2071793654 @default.
- W4309682774 cites W2082402714 @default.
- W4309682774 cites W2083702296 @default.
- W4309682774 cites W2084469135 @default.
- W4309682774 cites W2084701809 @default.
- W4309682774 cites W2092997044 @default.
- W4309682774 cites W2094188569 @default.
- W4309682774 cites W2096494798 @default.
- W4309682774 cites W2097172240 @default.
- W4309682774 cites W2098414192 @default.
- W4309682774 cites W2099848890 @default.
- W4309682774 cites W2101653483 @default.
- W4309682774 cites W2103708415 @default.
- W4309682774 cites W2104830962 @default.
- W4309682774 cites W2106586340 @default.
- W4309682774 cites W2108949840 @default.
- W4309682774 cites W2110930460 @default.
- W4309682774 cites W2113808566 @default.